Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
809.73
770.24
751.59
747.45
577.21
689.31
898.57
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
809.73
770.24
751.59
747.45
577.21
689.31
898.57
Raw Material Cost
372.51
339.12
330.04
385.27
260.26
260.00
216.90
Purchase of Finished goods
49.29
51.35
44.34
34.91
81.34
175.67
401.89
(Increase) / Decrease In Stocks
-8.11
-8.35
26.94
-29.20
-11.88
4.30
-6.53
Employee Cost
112.05
95.58
86.17
76.15
68.09
53.69
42.32
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
157.30
141.92
146.78
161.98
72.75
72.33
86.35
Total Expenditure (Excl Depreciation)
683.04
619.62
634.27
629.11
470.56
565.99
740.93
Operating Profit (PBDIT) excl Other Income
126.69
150.62
117.32
118.34
106.65
123.32
157.64
Other Income
36.49
28.74
17.79
31.49
20.22
39.19
37.63
Operating Profit (PBDIT)
163.18
179.36
135.11
149.83
126.87
162.51
195.27
Interest
8.12
6.91
10.36
4.74
5.51
7.57
4.41
Exceptional Items
0.00
-29.20
0.00
-73.59
0.00
-13.38
0.00
Gross Profit (PBDT)
155.06
143.25
124.75
71.50
121.36
141.56
190.86
Depreciation
29.42
26.38
18.67
17.33
17.23
12.59
8.94
Profit Before Tax
125.64
116.87
106.07
54.17
104.13
128.97
181.92
Tax
35.38
35.29
29.34
31.04
30.16
33.71
55.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
90.26
81.58
76.73
23.13
73.97
95.25
126.66
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
90.26
81.58
76.73
23.13
73.97
95.25
126.66
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-5.96
-6.12
-5.88
-8.09
-5.48
2.01
-2.94
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
84.30
75.45
70.86
15.04
68.49
97.27
123.72
Equity Capital
10.54
10.47
10.42
10.37
10.31
10.31
10.31
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,039.84
956.72
873.48
808.33
797.94
725.30
635.68
Earnings per share (EPS)
8.0
7.21
6.8
1.45
6.64
9.43
12.0
Diluted Earnings per share
7.95
7.11
6.72
1.43
6.49
9.43
11.99
Operating Profit Margin (Excl OI)
15.65%
19.55%
15.61%
15.83%
18.48%
17.89%
17.54%
Gross Profit Margin
19.15%
18.6%
16.6%
9.57%
21.03%
20.54%
21.24%
PAT Margin
11.15%
10.59%
10.21%
3.09%
12.82%
13.82%
14.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 5.13% vs 2.48% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 11.73% vs 6.48% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -15.89% vs 28.38% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 17.51% vs -33.30% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Bliss GVS Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
809.73
759.88
49.85
6.56%
Other Operating Income
0.00
0.00
0.00
Total Operating income
809.73
759.88
49.85
6.56%
Raw Material Cost
372.51
493.38
-120.87
-24.50%
Purchase of Finished goods
49.29
0.00
49.29
(Increase) / Decrease In Stocks
-8.11
-21.52
13.41
62.31%
Employee Cost
112.05
122.92
-10.87
-8.84%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
157.30
70.99
86.31
121.58%
Total Expenditure (Excl Depreciation)
683.04
665.77
17.27
2.59%
Operating Profit (PBDIT) excl Other Income
126.69
94.11
32.58
34.62%
Other Income
36.49
18.02
18.47
102.50%
Operating Profit (PBDIT)
163.18
112.13
51.05
45.53%
Interest
8.12
4.38
3.74
85.39%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
155.06
107.75
47.31
43.91%
Depreciation
29.42
27.99
1.43
5.11%
Profit Before Tax
125.64
79.76
45.88
57.52%
Tax
35.38
18.76
16.62
88.59%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
90.26
60.99
29.27
47.99%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
90.26
60.99
29.27
47.99%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-5.96
0.00
-5.96
Other related items
0.00
0.00
0.00
Consolidated Net Profit
84.30
60.99
23.31
38.22%
Equity Capital
10.54
10.48
0.06
0.57%
Face Value
1.00
5.00
0.00
Reserves
1,039.84
495.29
544.55
109.95%
Earnings per share (EPS)
8.00
29.10
-21.10
-72.51%
Diluted Earnings per share
7.95
28.87
-20.92
-72.46%
Operating Profit Margin (Excl OI)
15.65%
12.38%
0.00
3.27%
Gross Profit Margin
19.15%
14.18%
0.00
4.97%
PAT Margin
11.15%
8.03%
0.00
3.12%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 809.73 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 5.13% vs 2.48% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 84.30 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.73% vs 6.48% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 126.69 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -15.89% vs 28.38% in Mar 2024
Annual - Interest
Interest 8.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.51% vs -33.30% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.65%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
